481 results about "Chronic nephritis" patented technology

The invention discloses a new traditional Chinese medicine composition for treating the disease of chronic nephritis and a preparation method thereof. The composition mainly comprises the following raw medicines: tuckahoe, notopterygium root, atractylodes macrocephala koidz, oriental waterplantain rhizome, plantain seed, rhizoma atractylodis, officinal magnolia bark, areca peel, rheum officinale,chrysanthemum, taraxacum officinale root, amur corktree bark, rhizoma cyperi, eucommia bark, zanthoxylum pipertum, talc, Japanese climbing fern spore, glossy privet fruit, epimedium herb, semen alliituberose, angelica, pyrrosia lingua, akebiaquinata, medicated leaven, malt, gizzard pepsin, cape jasmine, immature bitter orange, pericarpium zanthoxyli, Chinese eaglewood, loosestrife, pollen typhaecarbonisatus, cacumen biotae carbonisatus and semen euryales. The composition can be prepared into any one common oral preparation according to the conventional traditional Chinese medicine preparation method. The composition can obviously improve the symptoms such as abdominal fullness and distention, anasarca, fatigue and heaviness, chest stuffiness and poor appetite, aching and limp waist and knees, extreme chilliness, palpitation and severe palpitation and the like, and features confirmed clinical effects, obvious and quick effects. The composition basically combines the medicinal and editable medicines specified in the State Pharmacopoeia, thus having the advantages of low cost and no toxic side effects basically, etc.

It is intended to provide preventives / remedies for graft-versus-host disease and / or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis. The above object can be achieved by preventives / remedies for graft-versus-host disease and / or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis characterized by containing a specific compound having a CCR (CC chemokine receptor) antagonism.

The invention relates to blueberry (vaccinium uliginosum) brandy and a production process thereof. The production process for the brandy is characterized in that the production process for blueberry spirit base and flavoring spirit comprises the following steps: fine-selecting of fresh fruits, crushing, fermentation, fermentation finishing, fermentation separation, freezing, re-warming fermentation, index control, distillation, storage, and storage in a cask. The spirit base and the flavoring spirit are blended and toned, the spirit reaching the standard is stored for 12 months, and then the spirit leaves factory after passing index detection. The brandy has good health-care effect on eyes, protects blood capillaries, resists oxidation, delays cranial nerve senescence, enhances memory, has good effect of eliminating in vivo inflammation, particularly has the most remarkable effect on urinary tract infection and chronic nephritis, and also has the anti-cancer and health-care effects.

The present invention relates to Chinese medicine for preventing and treating chronic renal lomerulus diseases, and is especially the medicine composition of one kind of compound Chinese medicine Tongmai oral liquid and its preparation process. The medicine composition is compounded with the effective parts of astragalus root, notoginseng, red sage and angelica, and contains compound polysaccharide and compound saponin in the ratio of 1-12. The medicine composition has the functions of benefiting Qi, promoting blood circulation, strengthening immunological stability, lowering the permeability of filtering membrane in renal lomerulus, improving microcirculation, etc., so that it can improve and stabilize kidney function.

The invention belongs to the technological field of the Chinese medicine, particularly relating to an extraction and separation processes of the active ingredients with the active function of treating the chronic glomerulonephritis. The mullein indican is the active compound researched and developed for many years in our research institute; the mullein indican is extracted, separated and refined from the digitalis leaf and is an active compound with the function of treating the chronic glomerulonephritis. The invention is the research result of many years held and developed by the Chinese Medicine Research Department of the Chinese Medicine Research Institute of China and is supported by the special fund of the Central Institute of the National Science and Technology Department; now the compound has been approved by the State Food and Drug Administration Bureau as the novel drug and the mechanism research of the treatment of the chronic nephritis has been completed; the pre-clinical research work includes the main pharmacodynamic experiment, the production technology experiment (including the industrialized extraction and separation processes), the quality control standard, the experiment of the affecting factors of the quality, the experiment of the long-term stability, the acute toxicity of the rat, the experiment of the long-term toxicity, the teratogenic and mutagenic experiment, the general pharmacological experiment, the pharmacokinetics experiment, and so on. The digitalis leaf is mainly produced in the Huaiqing area of the Henan province, and is also grown wild and cultivated in the Shaanxi, Hebei and other places of China.

The Yishenkangshuai pill for treating chronic nephrosis and renal failure incompetence is prepared with over 30 kinds of Chinese medicinal materials, including rhubarb, cooked aconite root, red ginseng, white ginseng, achyranthes root, etc. and through sorting material, washing, crushing, decocting, making pill, sterilizing and other steps. The present invention has the functions of benefiting kidney, nourishing essence, invigorating spleen, promoting diuresis, promoting blood circulation, detoxicating, etc. and is sued in treating failure incompetence, chronic nephritis, nephrosis syndromes and other nephrosis.

The invention relates to a traditional Chinese medicinal composition for treating chronic nephritis which comprises the following raw materials (by weight portion): root of red rooted saliva 30, astragalus root 30, Chinese angelica root 10, peach kernels 10, safflower 10, poria cocos wolf 30, corktree bark 12 and motherwort 30.

The present invention relates to a Chinese medicine composition for effectively curing chronic nephritis with excellent therapeutic effect. Said Chinese medicine composition contains 16 Chinese medicinal materials of ginseng, astragalus root, poria, white peony root, tangerine peel, licorice, jujube and others. Said Chinese medicine composition can be made into the tablet preparation, capsule preparation and granules preparation, etc.

The invention discloses a traditional Chinese medicine composition for treating chronic nephritis proteinuria, and the traditional Chinese medicine composition is mainly prepared by the following active pharmaceutical ingredients in parts by weight: 20-50 parts of raw membranous milkvetch root, 15-30 parts of pilose Asiabell root, 15-30 parts of Chinese peashrub root, 15-30 parts of raw coix seedroot, 18-30 parts of fructus forsythiae, 12-30 parts of honeysuckle flower, 18-30 parts of heartleaf houttuynia herb, 15-30 parts of spreading hedyotis herb, 9-20 parts of Szechuan lovage rhizome, 9-20 parts of tree peony bark, 15-30 parts of motherwort herb, 15-30 parts of Indian buead, 15-30 parts of corn silk and 15-30 parts of winged euonymus twig. In addition, the invention further disclosesa preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition can combine tonification with purgation, perform warming and cooling simultaneously,effectively eliminate the proteinuria and other pathological indicators of kidneys, delay and even block the progress of chronic nephritis and realize the significant protection effect for the kidneys.

The present invention relates to quinolyl amide derivatives, their preparation process, medicine compositions and use in preparing medicines for treating and / or preventing chronic nephritis, rheumarthritis, insulin dependent diabetes mellitus, systemic lupus erythematous, multiple sclerosis and other diseases.

The present invention relates to Chinese medicine composition, and especially a kind of Chinese medicine composition for treating kidney deficiency caused hair loss, kidney deficiency caused lumbago, chronic nephritis and neurasthenia and its preparation process. The Chinese medicine composition is preferably prepared into dripping pill and soft capsule.

The present invention relates to a medicine for curing kidney diseases. Said medicine is a Chinese medicine capsule preparation made from 20 Chinese medicinal materials of cooked rehmannia root, silkworm, bupleurum root, Chinese yam, astragalus root, leech and others through the processes of conventional water and alcohol double extraction. Said medicine can be used for curing the diseases of acute and chronic nephritis, purpuric nephritis, hepatitis B related nephritis, lupoid nephritis, nephrotic syndrome, renal insufficiency and diabetic nephritis, etc. Its cure rate is up to 92%.

The Chinese medicine for curing chronic nephritis and nephrotic syndrome, specially for curing side effect resulted from application of hormone and rebound phenomenon produced after hormone extenuation and medicine withdrawal with good therapeutic effect is a water-paste pill made up by using 8 Chinese medicinal matterials of lonicera stem and leaf, astragalus root, flowery knotweed, dioscorea root, pseudotellaria root, licorice, placenta powder and rhubarb as raw material. Its therapeutic effect is reliable, and its effective rate is above 95%, and it has no toxic side effect.

The invention discloses a Yougui capsule and a preparation method of the Yougui capsule. The Yougui capsule comprises the following raw materials: cooked rehmannia, giant typhonium rhizome, cassia bark, common yan rhizome, dogwood, south dodder seed, buckhom glue, fructus lycii, Chinese angelica root, and cortex eucommiae. According to the Yougui capsule and the preparation method of the Yougui capsule, a preparation process is improved on the basis of Yougui pills, the effective components of medicine in the formula are extracted effectively and the effect of treating kidney deficiency is improved; and the dosage form is changed, so that patients take the capsules easily and conveniently, and the patients' requirements on pharmaceutical effect and convenience of the medicine are satisfied. And most clinic applications prove that the Yougui capsule has remarkable curative effects on asynodia, spermatorrhea, chronic nephritis, nephropathy syndrome, osteoporosis, esteoproliferation, osteocomma aches, climacteric syndrome of women and sterility and the like.

The invention belongs to the medicine, processing and healthcare food technical field of cordyceps sinensis, particularly relating to a preparation method of the cordyceps sinensis extractive concentrated solution got by hirsrtella sinensis or hirsutella hepialid and applications of the cordyceps sinensis extractive concentrated solution in preparation of various preparation forms of medicine or healthcare products for strengthening and regulating immunity; thereby the solution can be applied for treating deficiency in lung and kidney, cancers and for helping strengthening immunity after themotherapy. The preparation of the invention is that the hirsrtella sinensis is fermented to produce cordyceps sinensis which is extracted respectively by ethanol, water and zymohydrolysis and then the extractive is condensed into concentrated solution which is produced into various preparation forms by spray-drying or directly produced into soft capsules after sterilization, and then the finished product is prepared well after packing and inspecting. No additive is added into the finished product which is composed of the extractive concentrated solution by 100 per cent. The various preparations prepared by the extractive concentrated solution of cordyceps sinensis all have multiple functions of restoring the deficiency in lung and kidney, strengthening immunity and enhancing resistance and have the function of regulating and steadying the immunological system of a human body, not only applicable to sub-healthy people for regular health care but also evident in efficacy for people who takes organ transplantation, cancer radiotherapy and chemotherapy, pneumonia, hepatitis, chronic nephritis and valetudinarianism.

The invention relates to medical technical field, relating to raspberry extract extracted from Rubus chingii Hu and raspberry element obtained from separating the raspberry extract and the application of the two in preparing medicines for treating and preventing chronic nephritis, kidney-yang deficiency and osteoporosis. The raspberry element has the following chemical structural formula. The raspberry extract and the raspberry element have activity of treating and preventing chronic nephritis, kidney-yang deficiency and osteoporosis, thereby being capable of preparing medicines for treating and preventing chronic nephritis, kidney-yang deficiency or osteoporosis.

The invention relates to a determination reagent against bilirubin interference based on a uricase method and an application method thereof. The reagent is a liquid double-reagent and has good resistance against bilirubin interference and excellent stability. The reagent can be used in a semi / full-automatic biochemical analyzer by adopting a two-point end assay method. By adopting a specific enzyme, the reagent has the characteristics of high sensitivity and strong anti-interference capability; and by adding a selected stabilizing agent, the reagent achieves good stability, namely, the reagent can be hermetically preserved at the temperature of 2-8 DGE C in dark place for 12 months without causing performance deterioration. The reagent can be widely applied to diagnosis, of kidney diseases such as acute and chronic nephritis, kidney stone, gout and the like as well as diseases resulting from excessive nucleic acid metabolism, such as leukemia, multiple myeloma and the like, physical examination and general investigation of kidney diseases and the like.

The Chinese medicine preparation for treating nephritis and nephrosis syndrome includes the following four kinds of active Chinese medicine components: the component for invigorating spleen and benefiting Qi, the component for promoting blood circulation to disperse blood clots, the component for clearing away heat and promoting urination, and the component for dispelling wetness and benefiting kidney. It has the functions of the components, and is used in treating chronic nephritis, pyelonephritis and nephrosis syndrome. Clinical application shows the Chinese medicine preparation is safe and has total effective rate up to 88.6 % and no toxic side effect.

The invention relates to caterpillar fungus stilbene ginseng capsule. The caterpillar fungus stilbene ginseng capsule is prepared from the following raw materials by weight: 140g of caterpillar fungus, 1,400g of astragalus membranaceus, 560g of salviae miltiorrhizae, 560g of safflower and 280g of spina date seed. The caterpillar fungus stilbene ginseng capsule disclosed by the invention treats both principal and secondary aspects of chronic nephritis, is easy to prepare, has an exact treatment effect, is based on a rigorous formula and has a wide application prospect.

The invention relates to the field of medical technology and provides an application of labdane diterpene glycoside compounds in rubus chingii Hu in preparing a medicine for preventing or treating chronic nephritis, kidney-yang deficiency, osteoporosis and prostatitis. The general formula of the chemical structure of the labdane diterpene glycosides in rubus chingii Hu is shown by the formula (I) in the specification. According to in-vivo animal experiments, the compounds provided by the invention have activity in preventing and treating chronic nephritis, kidney-yang deficiency, osteoporosis and prostatitis, wherein the curative effect of raspberry glycoside-F1-7 is better.

The invention relates to the technical field of fruit wine production. A pure fermented fruit wine comprises the raw materials: 81 percent of bog bilberry (blueberry) free-running juice and 19 percent of lonicera caerulea free-running juice. A production process comprises the following steps of: 1. fresh fruit selection; 2. detecting and weighing; 3. fresh fruit crushing; 4. canning; 5. separating; 6. free-running juice extraction; 7. two-fruit preferment; 8. lactic acid post-ferment; 9. low-temperature regulation; 10. index detection; 11. canning; 12. semi-finished product detection; 13. fine filtering; 14. bottling; 15. anthocyanin wine obtaining; 16. finished product detection; 17. putting in storage; and 18. delivering. The anthocyanin wine contains a large number of nutritional components of anthocyanin, bioflavonoid, vitamin, amino acids, organic acids and the like, and therefore, the anthocyanin wine has good health-care function to eyes and the functions of relieving the fatigue of the eyes, improving night vision, protecting blood capillary and resisting oxidation, delays cranial nerve aging, enhances memory, has good function of eliminating in vivo inflammations and especially has the obvious function on urinary tract infection and chronic nephritis and also has the anticancer function and the health-care function.

The invention belongs to the technical field of traditional Chinese medicines and in particular discloses a traditional Chinese medicine composite for treating chronic nephritis. The composite comprises the following raw materials in certain parts by weight: angelica, safflower, rhizoma smilacis glabrae, radix astragali, dandelion, cassia twig, radix morindae, plantain seed, aconite, golden thread, epimedium herb, perilla stem, rheum officinale, leonurus, oyster, lalang grass rhizome and liquorice. The composite is simple in preparation, good in absorption effect, obvious in curative effect, free of side effects and high in safety, and is beneficial to timely alleviating symptoms of the disease.

The invention relates to a traditional Chinese medicine composition for treating chronic enteritis and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following crude drugs in parts by weight: 12-24 parts of eclipta, 12-24 parts of hairyvein agrimony, 12-24 parts of herba portulacae, 7-13 parts of radix paeoniae alba, 7-13 parts of radix paeoniae alba, 7-13 parts of honeysuckle, 7-13 parts of smoked plum, 7-13 parts of field pennycress, 4-8 parts of angelica sinensis, 4-8 parts of codonopsis pilosula, 4-8 parts of platycodon grandiflorum, 4-8 parts of white atractylodes rhizome, 4-8 parts of root of kudzu vine, 4-8 parts of astragalus membranaceus, 4-8 parts of bark of ash, 4-8 parts of radices sileris, 4-8 parts of immature bitter orange, 4-8 parts of coptis chinensis, 4-8 parts of endothelium corneum gigeriae galli, 2-4 parts of elecampane, 2-4 parts of pericarpium citri reticulatae, 2-4 parts of rhizoma zingiberis and 2-4 parts of liquorice. The traditional Chinese medicine composition has the advantages of being significant in curative effect, less in possibility of chronic nephritis reappear, small in side effect, and simple in preparation method.

The utility model provides a Chinese traditional medicine for curing the chronic nephritis and nephropathy syndrome; the present invention consists of the following raw materials according to corresponding weight proportion of 10 to 50 portion of aweto, 10 to 50 portion of wild glossy ganoderma, 5 to 40 portion of Tibet safflower, 10 to 80 portion of gecko, 10 to 80 portion of cicada slough, 5 to 80 portion of ginseng, 5 to 50 portion of frankincense, 5 to 50 portion of myrrh, 5 to 80 portion of Tianshan snow lotus, 10 to 100 portion of cornel, 10 to 80 portion of prepared rhizome of rehmannia, 10 to 80 portion of root of red salvia, 10 to 80 portion of red peony, 5 to 70 portion of Paris chinensis, 5 to 80 portion of angelica, 10 to 100 portion of honeysuckle, 5 to 50 portion of leech, 5 to 50 portion of ledeboruiella root, 10 to 60 portion of oriental water plantain rhizome and 5 to 80 portion of gynura segetum. The preparation can take effect quickly and the curative effect is stable; with the preparation, the manifestation and the root cause of the disease can be cured; the preparation is convenient for taking and the dosage is less and the price is low.

The invention relates to a traditional Chinese medicine composition, especially a traditional Chinese medicine composition for treating chronic nephritis, composed of the following raw materials by weight: astragalus root 15g, achyranthes root 15g, mulberry bark 10g, moutan bark 15g, dried rehmannia root 12g, ginseng 10g, tuckahoe 10g, cornel 15g, pinellia 10g, medlar 12g, caterpillar fungus 10g, atractylodes rhizome 12g, wofberry bark 20g, ledebouriella root 15g, tortoise plastron 12g, Chinese yam 20g, glycyrrhizae 5g. The traditional Chinese medicine composition has obvious effect on treating chronic nephritis, with high curative rate and great clinical generalization value.

The invention relates to a Chinese medicinal preparation for treating a nephrotic syndrome and a preparation method. The raw materials of active ingredients of the prepared Chinese medicinal preparation consist of astragalus, eucommia bark, pyrrosia leaf, stem and leaf of assan crotalaria, pine leaf, stem and leaf of wallich pepper, rhizome of david anemone, lygodium japonicum, mosla scabra, herb of spanishneedles, rust-coloured crotalaria herb with root, gentianopsis barbata, cottonrose hibiscus root, root of cluster mallow, purple flower holly leaf and brittle falsepimpernel herb. The Chinese medicinal preparation has the effects of invigorating spleen, supplementing qi, tonifying kidney, strengthening body resistance, activating blood circulation to dissipate blood stasis, clearing heat and inducing diuresis, can be used for treating diseases such as chronic nephritis, pyelonephritis and nephrotic syndrome, has the characteristics of clear curative effect, safety, convenience, no toxic or side effect, quick response and low probability of relapse and has a total effective ratio of being over 90 percent on the treatment of the nephrotic syndrome.

The invention discloses an oral traditional Chinese medicinal combination used for treating chronic nephritis, which belongs to a field of traditional Chinese medicine.The oral traditional Chinese medicinal combination used for treating the chronic nephritis is formulated by certain weight of rehmannia root, tortoise plastron, cornus dogwood fruit, moutan bark, cyathula root, astragalus root, Chinese wolfberry fruit, Chinese caterpillar fungus, poria, Chinese ephedra, white mulberry, atractylodes macrocephala, divaricate saposhnikovia root and dioscorea root. The medicine is decocted and taken once separately in the morning and the night, one dose per one day. Enduring drug potency of the drug efficacy combining with the effect continuously act on the nidus, which achieve an effect of treating both manifestation and root cause, and can overall nourish and improve as well as put an end to relapse with dramatic healing efficacy.

Disclosed is a medicament for treating nephritis and uremia comprising medicament A, medicament B and externally used medicament, wherein the medicament A comprises 16 kinds of Chinese herbs including codonopsis pilosula, astragalus root and motherwort fruit, the medicament B comprises 9 kinds of Chinese herbs including rhubarb horsetails, mirabilite and baikal skullcap root. The externally used medicament comprises 11 kinds Chinese raw material herbs including scorpion, leeches and radix euphorbiae ebracteolatae.

The invention relates to a traditional Chinese medicine composition for treatment of chronic nephritis, and the medicine is prepared from the following 18 traditional Chinese medicines according to a certain weight ratio: radix astragali, oriental waterplantain rhizome, bighead atractylodes rhizome, cape jasmine, Chinese yam, tree peony bark, ginseng root, Pyrrosla lingua, cortex lycii, Poria cocos, achyranthes root, plantain seeds, mulberry bark, raw rehmannia root, Cornus officinalis, root back of Paeonia suffruticosa, rehmanniae radix, and Cordyceps sinensis. The invention is characterized by definite therapeutic effect, high cure rate, safety and convenience, no toxic or side effect, and a low price.

The present invention discloses a Chinese medicine composition for effectively curing nephritis and its application. Said Chinese medicine composition is composed of the Chinese medicinal materials of pennywort, centella, wild chrysanthemum flower, persimmon leaf, astragalus root and plantago, etc. It can be made into various oral dosage forms. Besides, said invention also provides its preparation method and concrete steps.